Principal Scientist
Amgen
Thousand Oaks, California
Kimya Nourbakhsh is a Principal Scientist at Amgen (Thousand Oaks, CA) within Process Development Attribute Sciences. In her current role, Kimya is a member of the Attribute Impact team responsible for assessing drug product attributes, holding, and disseminating attribute knowledge, and supporting regulatory filings. Thus far in her role, she has led the development and execution of several studies and team efforts to de-risk attributes, bolster drug safety, and collaborate across industry. Kimya is an active member of scientific societies and currently serves as Member Engagement Manager for the AAPS Biopharmaceutical Product Attributes and Biological Consequences Community (BPABC). Prior to joining Amgen, she earned her B.S. in Biochemistry/Chemistry from UC San Diego and a Ph.D. in Pharmacology from University of Washington.
Disclosure information not submitted.
Silicone Oil Particles in Protein Drug Product – Are These a Significant Immunogenicity Risk Factor?
Tuesday, May 14, 2024
10:20 AM – 10:40 AM PT
Tuesday, May 14, 2024
10:40 AM – 11:00 AM PT